Almost every Spravato clinic explains the medical side of treatment.
Very few explain the psychological side honestly.
Patients are told:
- “You may experience dissociation.”
- “You may feel sedated.”
- “Some people notice perceptual changes.”
But those phrases are clinical abstractions.
They do not explain what the experience actually feels like as a human being sitting in a treatment chair wondering:
“Am I okay?”
“Is this normal?”
“Why does time feel strange?”
“Why do I suddenly feel emotional?”
“Why do I feel detached from myself?”
“Why do other people describe life-changing experiences while I feel nothing?”
At Amicus Health and Wellness in Tempe, Arizona, one of the most important parts of Spravato treatment is preparing patients emotionally and psychologically before treatment begins.
Because many patients are not primarily afraid of the medication itself.
They are afraid of entering an unfamiliar mental state nobody has explained clearly.
And honestly, that fear makes sense.
What Is Spravato?
Spravato is the brand name for esketamine, an FDA-approved treatment for:
- treatment-resistant depression
- depressive symptoms associated with major depressive disorder with acute suicidal ideation or behavior
Unlike traditional antidepressants that mainly target serotonin systems, Spravato affects glutamate pathways involving NMDA receptor modulation.
Research published in JAMA Psychiatry and indexed through PubMed demonstrated significant antidepressant effects in treatment-resistant depression populations.
Because Spravato can produce temporary sedation and dissociation, the medication is administered within a REMS-certified medical setting under supervision.
The REMS program exists specifically because of:
- sedation concerns
- dissociation risk
- temporary perceptual changes
- safety monitoring requirements
But many patients hear the word “dissociation” without anyone explaining what that actually means experientially.
Most Patients Are Already Anxious Before Treatment Starts
Patients seeking Spravato treatment are rarely entering care from a place of emotional stability.
Many already feel:
- exhausted
- hopeless
- emotionally overwhelmed
- frightened by prior treatment failures
- skeptical of psychiatric medications
Then they read online about:
- altered perception
- dissociation
- detachment
- hallucination fears
- sedation
Some patients begin imagining catastrophic experiences before treatment even starts.
Others spend nights searching Reddit or watching TikTok videos trying to understand:
“What does Spravato actually feel like?”
This anxiety is incredibly common.
And much of it comes from poor preparation.
What Dissociation Actually Feels Like
Clinically, dissociation sounds alarming.
But for many patients, the experience is more subtle and difficult to describe than dramatic.
Research indexed through PubMed has documented dissociative symptoms during esketamine treatment sessions, including perceptual and awareness changes.
In plain human language, patients often describe dissociation as:
- feeling mentally distant from stress
- feeling emotionally detached temporarily
- feeling dreamlike
- feeling internally quiet
- feeling disconnected from normal thought intensity
Some people explain it as:
“It felt like my thoughts slowed down.”
“It felt like I was observing my mind instead of drowning in it.”
“It felt strange but not necessarily bad.”
“It felt like emotional static quieted temporarily.”
Others dislike the sensation because unfamiliar mental states naturally create anxiety.
The experience varies significantly between individuals.
Altered Perception of Time Is Extremely Common
One of the most surprising psychological effects during Spravato sessions involves time distortion.
Patients often say:
“I thought an hour passed.”
“I felt like time stopped.”
“Everything felt suspended.”
Time may seem:
- slower
- faster
- fragmented
- emotionally distant
This altered time perception is one of the reasons patients sometimes become anxious during treatment if nobody prepared them beforehand.
Humans rely heavily on consistent orientation to:
- time
- environment
- body awareness
When perception shifts temporarily, the brain naturally reacts with uncertainty.
The important thing patients need to understand is this:
Temporary time distortion during monitored Spravato treatment is common and expected.
Emotional Detachment Can Feel Scary Initially
Many patients with treatment-resistant depression already struggle feeling emotionally disconnected before treatment.
So when Spravato temporarily increases emotional detachment or dissociation, some panic immediately.
Patients may think:
“I am disappearing emotionally.”
“What if I stay like this?”
“What if I lose myself?”
But temporary emotional distance during treatment does not mean psychological harm is occurring.
For some patients, emotional detachment actually feels relieving because depression itself often involves relentless emotional pain, intrusive thoughts, or chronic internal tension.
Patients sometimes describe:
“It felt like my mind finally got quiet.”
“I could step outside my emotional pain temporarily.”
“I was not drowning in my thoughts for once.”
Others find it uncomfortable because emotional unfamiliarity creates vulnerability.
Both reactions can be normal.
Derealization Is One of the Hardest Symptoms to Explain
Derealization is another experience patients rarely understand beforehand.
It may feel like:
- the environment seems dreamlike
- surroundings feel emotionally distant
- reality feels slightly unfamiliar
- sensory perception changes subtly
Patients often say:
“The room looked normal but felt strange.”
“It felt like I was watching reality rather than fully inside it.”
“Everything felt slightly unreal.”
This can sound frightening if patients are unprepared.
But temporary derealization during supervised Spravato treatment is recognized clinically and monitored specifically because it can occur.
The problem is not usually the sensation itself.
The problem is patients believing:
“This should not be happening.”
Preparation changes the experience dramatically.
Temporary Anxiety During Sessions Is More Common Than Clinics Admit
Many clinics unintentionally oversimplify Spravato treatment emotionally.
Patients are often led to believe the experience will feel immediately calming or euphoric.
That is not always true.
Some individuals experience temporary anxiety during sessions involving:
- fear of losing control
- increased self-awareness
- physical sensitivity
- uncertainty
- nervous system activation
Research published in JAMA Network Open continues evaluating esketamine safety and tolerability across treatment-resistant depression populations.
Patients with:
- trauma histories
- panic disorder
- generalized anxiety
- obsessive thinking
- hypervigilance
may feel especially vulnerable during altered perceptual experiences.
This does not automatically mean treatment is going badly.
Why Some Patients Cry After Sessions
One of the least discussed aspects of Spravato treatment is emotional release.
Some patients unexpectedly cry:
- during treatment
- immediately afterward
- later that evening
Often they cannot fully explain why.
Patients may cry because:
- chronic emotional suppression softens temporarily
- internal tension decreases
- hopelessness shifts
- emotional responsiveness returns
- relief feels overwhelming
Many patients with severe depression become emotionally numb over time.
When emotional access begins returning, crying may emerge unexpectedly.
Patients often say:
“I did not realize how emotionally shut down I had become.”
“It felt like years of pressure released.”
“I finally felt human again.”
This emotional release can feel intense but not necessarily dangerous.
Why Others Feel Nothing Initially
One of the biggest misconceptions about Spravato is the belief that every session produces a profound emotional breakthrough.
That is not reality.
Some patients feel:
- mild relaxation
- subtle detachment
- emotional quietness
Others feel almost nothing initially.
This creates panic for many people because they expected:
- dramatic insight
- immediate relief
- emotional transformation
Research published in JAMA Psychiatry demonstrated variability in response patterns among patients receiving esketamine treatment.
Some patients improve gradually across multiple sessions rather than through one dramatic experience.
Lack of intense dissociation does not necessarily mean treatment failed.
And intense dissociation does not automatically predict better outcomes either.
Why Preparation Changes the Entire Experience
One of the biggest predictors of patient comfort during Spravato treatment is preparation.
Patients who understand:
- what dissociation feels like
- what sensations are expected
- what anxiety may occur
- what temporary perceptual changes mean
are far less likely to panic.
Fear decreases when experiences become understandable.
Patients often tolerate sessions much better when they hear beforehand:
“You may feel detached.”
“Time may feel unusual.”
“You may feel emotional.”
“You may feel very little.”
“All of those reactions can happen.”
That honesty matters enormously.
What Is Normal vs Concerning?
Patients deserve clear explanations regarding what is expected versus what requires clinical attention.
Common temporary experiences may include:
- altered time perception
- mild dissociation
- emotional release
- sedation
- dizziness
- temporary anxiety
- derealization
- emotional detachment
These effects are specifically why monitoring occurs.
The REMS program exists because dissociation and sedation are recognized clinical effects requiring observation and safety precautions.
Concerning symptoms requiring immediate clinical evaluation may involve:
- severe agitation
- dangerous confusion
- prolonged instability
- acute medical symptoms
- severe psychological distress not resolving appropriately
This is precisely why supervised treatment settings matter.
Why the REMS Monitoring Program Exists
Many patients initially view monitoring requirements as excessive.
But the REMS structure exists specifically because of:
- sedation concerns
- dissociation monitoring
- blood pressure changes
- temporary impairment risks
Patients remain under observation after treatment because the experience temporarily affects awareness and perception.
The official Spravato REMS Program requires certified treatment settings and monitoring protocols designed for patient safety.
This is not punishment.
It is protection.
Trauma Histories Often Intensify the Experience
Patients with trauma histories may experience stronger anxiety surrounding altered perception.
Trauma survivors often rely heavily on:
- control
- predictability
- environmental awareness
- nervous system vigilance
Temporary dissociation may initially feel threatening because it reduces normal control mechanisms.
Trauma-informed psychiatric care becomes critically important during Spravato treatment.
Patients need:
- preparation
- emotional reassurance
- clear communication
- calm environments
- psychological safety
The relational environment surrounding treatment affects the experience significantly.
Some Patients Feel More Vulnerable After Sessions
Another under-discussed reality is emotional vulnerability afterward.
Patients may leave sessions feeling:
- emotionally open
- reflective
- sensitive
- mentally tired
- psychologically exposed
Some individuals feel deeply introspective for hours afterward.
Others simply feel fatigued.
This vulnerability is one reason patients should not immediately:
- drive
- return to stressful work environments
- make major emotional decisions
- overstimulate themselves socially
Recovery time matters.
The Psychological Experience Is Often More Human Than Clinical
One reason patients become frightened is because clinics often describe Spravato entirely in technical language.
But the actual experience is deeply human.
Patients are not just experiencing:
- NMDA receptor modulation
- glutamatergic activity
- dissociation scales
They are experiencing:
- fear
- hope
- vulnerability
- relief
- emotional uncertainty
- psychological exposure
That emotional reality deserves acknowledgment.
The Goal Is Not Emotional Escape
Some patients fear Spravato will make them emotionally disconnected permanently.
Others fear it exists simply to numb suffering artificially.
But the goal of treatment is not emotional escape.
The goal is reducing the severe depressive burden preventing:
- emotional connection
- functioning
- motivation
- hope
- quality of life
For some patients, temporary dissociation creates psychological distance from relentless depressive suffering long enough for recovery processes to begin.
Patients Deserve Better Conversations Before Treatment
At Amicus Health and Wellness in Tempe, Arizona, psychiatric care surrounding Spravato treatment focuses heavily on realistic preparation because psychological understanding changes patient experience profoundly.
Most patients are not asking for perfection.
They simply want someone to explain honestly:
- what the experience may feel like
- what is normal
- what may feel emotionally strange
- why monitoring exists
- why fear itself is understandable
Because patients become far less terrified when somebody finally explains the experience in human language instead of clinical euphemisms.
And sometimes the most important thing a patient hears before treatment is:
“You are not losing your mind.”
“This experience is temporary.”
“You are safe.”
“You are not alone in feeling this way.”